Channels - Role of the UHRF1–KLHL6–CORO2B axis in obesity‐related insulin resistance :: FRELIP Discovery

Similar Items: Role of the UHRF1–KLHL6–CORO2B axis in obesity‐related insulin resistance

Quick Look
Sestrin-2: a new biomarker for type 2 Diabetes Mellitus and Insulin resistance
Quick Look
Efficacy and Safety of Insulin Efsitora Versus Degludec in Adults with Type 2 Diabetes Who Are Insulin-Naïve: Japan Subgroup Analysis of QWINT-2
Quick Look
Associations of finerenone with reduced insulin resistance in patients with type 2 diabetes and chronic kidney disease: A real‐world observational study
Quick Look
Impact of obesity and type 2 diabetes on muscle power, quality, and force–velocity, and their relation to functional capacity
Quick Look
Time in range during caloric restriction in type 2 diabetes with obesity
Quick Look
Optimizing Type 2 Diabetes Management in Iraq: Expert Consensus on Initiation and Intensification of Insulin-Based Treatment Options
Quick Look
Insulin‐reducing effect of adding imeglimin to ongoing dipeptidyl peptidase‐4 inhibitor therapy with multiple daily insulin injections (INSPIRE study)
Quick Look
Correspondence: Effects of short‐term tofogliflozin treatment on insulin secretory capacity in type 2 diabetes: Insights and future directions
Quick Look
Basal Insulin Adherence in Patients with Type 2 Diabetes Mellitus in Routine Clinical Practice in Spain: Clinical and Economic Impact
Quick Look
Association Between Anthropometric Indices and Presence of Type 2 Diabetes Mellitus in Obesity
Quick Look
Correction to “Effects of short‐term tofogliflozin treatment on the insulin secretory capacity of people with type 2 diabetes: A randomized controlled trial, the TOP‐2ELM study”
Quick Look
Methodological considerations in the assessment of time in range during caloric restriction in type 2 diabetes with obesity
Quick Look
Real-time continuous glucose monitoring in adults with type 2 diabetes managed with non-intensive insulin regimens: impact on glycemia and self-management
Quick Look
Risk of biliary diseases in patients with type 2 diabetes or obesity treated with tirzepatide: A critical appraisal
Quick Look
Five‐year follow‐up of incretin‐based therapy in a patient with KCNJ11‐related permanent neonatal diabetes: Achieving insulin discontinuation and sulfonylurea reduction
Quick Look
Cost‐effectiveness analysis comparing real‐time continuous glucose monitoring with self‐monitoring of blood glucose for patients with type 2 diabetes treated with insulin in Japan
Quick Look
Pen Needle Reuse in People with Diabetes Who Inject Insulin: A Narrative Review
Quick Look
Effectiveness of tirzepatide in Japanese patients with type 2 diabetes but no obesity: A sub‐analysis of Hokkaido‐TZP study data
Quick Look
Efficacy and safety of GLP-1RA on cardio-metabolic outcomes in overweight or obese Chinese adults: a systematic review and meta-analysis
Quick Look
Clinical characteristics of Sarcopenic obesity in Japanese people with type 2 diabetes: A post hoc analysis of the sub‐cohort iDIAMOND study
Quick Look
Cardiovascular outcomes of glucagon-like peptide-1 receptor agonists in patients without obesity: a systematic review and meta-analysis of randomized controlled trials
Quick Look
Metabolic dysfunction–associated steatotic liver disease and cardiovascular disease: Emerging insights into the liver–heart axis
Quick Look
Real-World Performance of the MiniMed 780G Advanced Hybrid Closed Loop Automated Insulin Delivery System in Greece
Quick Look
Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category